Lupus Nephritis
Lupus nephritis is a complication of systemic lupus erythematosus (SLE) that causes inflammation in the kidneys, potentially leading to kidney damage. It can affect how well your kidneys filter waste from your blood.
Lupus Nephritis: MSV-ALLO® Treatment Study
We are testing a new cell therapy for lupus nephritis to see if it helps patients achieve remission. The study compares this treatment to a placebo to evaluate its safety and effectiveness.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have a diagnosis of Systemic Lupus Erythematosus (SLE)?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications like corticosteroids or mycophenolate for your condition?
- Have you had any major surgeries in the last 6 weeks?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Msv-allo
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitario Rio Hortega
Hematology
Valladolid, Spain
Sponsor: Hospital Universitario Rio Hortega
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.